# Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab Era

> **NCT03663894** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 95 (actual)

## Conditions studied

- Patient's Outcome Prognostic Factors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03663894
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-30
- **Primary completion:** 2017-12-15
- **Final completion:** 2018-07-31
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2018-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03663894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03663894, "Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab Era". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03663894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*